L-type amino-acid transporter 1 (LAT1) is the first identified light chain of CD98 molecule, disulfide-linked to a heavy chain of CD98. Following cDNA cloning of chicken full-length LAT1, we have constructed targeting vectors for the disruption of chicken LAT1 gene from genomic DNA of chicken LAT1 consisting of 5.4kb. We established five homozygous LAT1-disrupted (LAT1(-/-)) cell clones, derived from a heterozygous LAT1(+/-) clone of DT40 chicken B cell line. Reactivity of anti-chicken CD98hc monoclonal antibody (mAb) with LAT1(-/-) DT40 cells was markedly decreased compared with that of wild-type DT40 cells. All LAT1(-/-) cells were deficient in L-type amino-acid transporting activity, although alternative-splice variant but not full-length mRNA of LAT1 was detected in these cells. LAT1(-/-) DT40 clones showed outstandingly slow growth in liquid culture and decreased colony-formation capacity in soft agar compared with wild-type DT40 cells. Cell-cycle analyses indicated that LAT1(-/-) DT40 clones have prolonged cell-cycle phases compared with wild-type or LAT1(+/-) DT40 cells. Knockdown of human LAT1 by small interfering RNAs resulted in marked in vitro cell-growth inhibition of human cancer cells, and in vivo tumor growth of HeLa cells in athymic mice was significantly inhibited by anti-human LAT1 mAb. All these results indicate essential roles of LAT1 in the cell proliferation and occurrence of malignant phenotypes and that LAT1 is a promising candidate as a molecular target of human cancer therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2011.02.135 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Splice site and de novo variants can cause PLCG2-associated immune dysregulation with cold urticaria.
J Allergy Clin Immunol
December 2024
Translational Genetics and Genomics Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Md. Electronic address:
Article Synopsis
- PLCγ2 is a key signaling molecule involved in immune regulation, and its variants can lead to conditions like PLCγ2-associated immune dysregulation (PLAID), particularly PLAID with cold urticaria (PLAID-CU), caused by specific genetic mutations.
- Researchers conducted a study combining RNA sequencing and whole genome sequencing to identify genetic lesions in patients with antibody deficiency and known PLAID-CU cases.
- The study found that two probands had novel PLCG2 transcripts with in-frame deletions linked to splice site mutations and deletions, which resulted in impaired ERK phosphorylation in a model system, highlighting the role of these genetic alterations in PLAID-CU.
Molecular details and phosphoregulation of the CENP-T-Mis12 complex interaction during mitosis in DT40 cells.
iScience
December 2024
Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan.
To establish bipolar attachments of microtubules to sister chromatids, an inner kinetochore subcomplex, the constitutive centromere-associated network (CCAN), is assembled on centromeric chromatin and recruits the microtubule-binding subcomplex called the KMN network. Since CCAN proteins CENP-C and CENP-T independently bind to the Mis12 complex (Mis12C) of KMN, it is difficult to evaluate the significance of each interaction in cells. Here, we demonstrate the molecular details of the CENP-T-Mis12C interaction using chicken DT40 cells lacking the CENP-C-Mis12C interaction.
View Article and Find Full Text PDFPrimPol-mediated repriming elicits gap-filling by template switching and promotes cellular tolerance to cidofovir.
DNA Repair (Amst)
November 2024
Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1, Hachioji-shi, Tokyo 192-0397, Japan. Electronic address:
A nucleoside analog, Cidofovir (CDV), is used for the treatment of viral diseases such as cytomegalovirus retinitis and herpes virus infection. CDV converts to its active diphosphate metabolite (CDVpp) through cellular kinases and acts as a competitive inhibitor for viral polymerase thereby interfering with viral replication. However, the effect of this drug on the replication of healthy host cells and the mechanisms involved in the cellular tolerance to CDV are yet to be fully understood.
View Article and Find Full Text PDFEpigenetic modulation via the C-terminal tail of H2A.Z.
Nat Commun
October 2024
Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
H2A.Z-nucleosomes are present in both euchromatin and heterochromatin and it has proven difficult to interpret their disparate roles in the context of their stability features. Using an in situ assay of nucleosome stability and DT40 cells expressing engineered forms of the histone variant we show that native H2A.
View Article and Find Full Text PDFThe flap endonuclease-1 mediated maturation of Okazaki fragments is critical for the cellular tolerance to remdesivir.
DNA Repair (Amst)
December 2024
Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1,Hachioji-shi, Tokyo 192-0397, Japan. Electronic address:
Remdesivir is a 1'-cyano-modified adenine nucleotide analog used for the treatment of COVID-19. Recently, the anti-carcinogenic effect of remdesivir has been also identified in human cancers. However, the impact of this drug and the mechanisms underlying the cellular tolerance to remdesivir have not been elucidated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!